.svg){kind=icon}
Bisabolol is a lesser-known cannabis terpene with an unusually strong connection to skin-care and dermatologic research.
Also called alpha-bisabolol or levomenol, this aromatic compound is found naturally in chamomile, cannabis, and several other plants. It has been used for years in cosmetic and topical formulations because of its mild aroma and skin-soothing properties.
Scientists have also investigated alpha-bisabolol for potential anti-inflammatory, antioxidant, wound-healing, and dermatologic effects.
That makes bisabolol particularly interesting within medical cannabis education.
However, there is an important distinction between purified bisabolol used in laboratory or dermatology research and the relatively small amounts found naturally within a cannabis terpene profile.
Finding bisabolol on a cannabis laboratory report does not mean the product has been proven to treat eczema, inflammation, wounds, or another skin condition.
What Is Bisabolol?
Bisabolol is a sesquiterpene alcohol.
The form most commonly studied is alpha-bisabolol.
It occurs naturally in plants including:
- German chamomile
- Candeia trees
- Sage
- Certain aromatic herbs
- Cannabis
Its aroma is generally described as:
- Floral
- Sweet
- Mild
- Herbal
- Chamomile-like
Compared with terpenes such as limonene or pinene, bisabolol usually has a softer aroma.
In cannabis, it commonly appears as a minor terpene rather than the dominant component of the terpene profile.
Why Bisabolol Is Important in Dermatology
Bisabolol has been used extensively in cosmetics and topical skin products.
It may appear in:
- Moisturizers
- Sensitive-skin products
- After-shave products
- Cosmetic creams
- Skin-soothing formulations
- Dermatologic preparations
Researchers have been interested in bisabolol because experimental studies suggest it can influence inflammation and skin-cell signaling while generally being well tolerated in topical formulations.
Its history in dermatology gives bisabolol a somewhat different scientific background from many cannabis terpenes.
For example, terpinolene research is heavily focused on chemistry and oxidation, while ocimene research is often centered on plant biology.
Bisabolol has been studied directly in skin-related contexts.
Bisabolol and Inflammation
Inflammation is one of the best-studied areas of alpha-bisabolol pharmacology.
Laboratory and animal studies have found effects involving inflammatory mediators such as:
- TNF-alpha
- IL-1 beta
- IL-6
- COX-2
- iNOS
- NF-kappa B
- MAPK signaling
These pathways help regulate immune and inflammatory responses.
Experimental studies have shown that alpha-bisabolol can reduce certain inflammatory signals under controlled conditions.
That provides a biological explanation for why bisabolol has been explored in dermatologic formulations.
But the evidence should be described accurately.
It supports anti-inflammatory activity in experimental models.
It does not establish bisabolol-rich cannabis as an approved treatment for inflammatory disease.
Bisabolol and Skin Inflammation
Researchers have specifically studied alpha-bisabolol in models of skin inflammation.
In experimental work, topical bisabolol has reduced:
- Swelling
- Inflammatory-cell activity
- Pro-inflammatory cytokines
- Tissue damage
- Oxidative changes
These findings make bisabolol an interesting candidate for further dermatologic research.
Skin inflammation, however, is not one condition.
Inflammation associated with:
- Atopic dermatitis
- Contact dermatitis
- Psoriasis
- Skin injury
- Infection
- Allergic reactions
can involve different biological mechanisms.
A compound affecting one inflammatory pathway may not work equally well across every dermatologic condition.
What Human Atopic Dermatitis Studies Show
Unlike many cannabis terpenes, bisabolol has appeared in human dermatology research.
One randomized study evaluated topical levomenol, another name for alpha-bisabolol, in patients with atopic dermatitis.
A combination of levomenol and heparin improved itching and dermatitis severity more than either ingredient alone or the vehicle.
That is meaningful clinical evidence—but it has an important limitation.
The strongest results came from a combination formulation.
This means the study does not prove that bisabolol alone would produce the same outcome.
Other clinical studies have also evaluated creams containing bisabolol alongside ingredients such as zinc oxide, glycyrrhetinic acid, moisturizers, or other skin-supporting compounds.
Those formulations have shown encouraging results, but once again, the effects cannot be assigned entirely to bisabolol.
Bisabolol and the Skin Barrier
Healthy skin depends on an effective outer barrier.
This barrier helps prevent:
- Excessive water loss
- Irritant penetration
- Microbial exposure
- Environmental damage
Conditions such as atopic dermatitis can involve impaired skin-barrier function.
Some bisabolol-containing topical formulations have been associated with improvements in hydration, itching, redness, and barrier-related measures.
However, these products often contain several moisturizing and barrier-supporting ingredients.
Bisabolol should therefore be viewed as one possible contributor rather than a complete skin-barrier treatment by itself.
Bisabolol and Wound-Healing Research
Bisabolol has also been investigated in wound-healing research.
Animal experiments have reported changes involving:
- Tissue repair
- Fibroblast activity
- Wound strength
- Inflammatory signaling
Human research has also examined formulations containing alpha-bisabolol for chronic wounds.
One randomized study involving venous leg ulcers evaluated a combination spray containing ozonated oil and alpha-bisabolol.
The treatment group showed greater reductions in ulcer size than the comparison group.
Again, there is an important limitation:
The formulation contained both ozonated oil and bisabolol.
The results therefore cannot prove that bisabolol alone caused the improvement.
Patients should never apply cannabis products to an open wound unless specifically directed by an appropriate healthcare professional.
Bisabolol and Oxidative Stress
Inflammation and oxidative stress often occur together.
Experimental research has found that alpha-bisabolol may affect oxidative pathways and markers associated with reactive oxygen species.
Researchers have reported effects involving:
- Lipid peroxidation
- Antioxidant enzymes
- Reactive oxygen species
- Cellular stress pathways
This provides another possible mechanism for bisabolol's experimental skin effects.
But describing cannabis-derived bisabolol as a clinically proven antioxidant treatment would go beyond current evidence.
Is Bisabolol a Cannabinoid?
No.
Bisabolol is a terpene.
THC, CBD, CBG, CBC, and CBN are cannabinoids.
Unlike THC, bisabolol is not known primarily for activating CB1 receptors.
Its biological activity appears to involve inflammatory, oxidative, cellular, and other signaling pathways outside classical cannabinoid-receptor pharmacology.
That makes it part of the broader chemistry of cannabis without making it a cannabinoid.
Does Bisabolol Get You High?
No.
Bisabolol does not produce the classic THC intoxication associated with CB1 receptor activation.
However, a cannabis product containing bisabolol may still contain substantial THC.
That means the product itself can still cause:
- Intoxication
- Memory changes
- Slower coordination
- Altered perception
- Anxiety
- Sedation
The presence of bisabolol does not reduce the importance of THC dose.
Bisabolol in Cannabis Topicals
Because bisabolol has a strong history in dermatologic products, it is tempting to assume that a cannabis topical containing bisabolol will automatically be superior.
That conclusion is premature.
The effect of a topical cannabis product depends on the entire formulation, including:
- Cannabinoids
- Terpenes
- Oils
- Emulsifiers
- Moisturizers
- Penetration enhancers
- Concentration
- Application area
It is also important to distinguish topical from transdermal products.
A topical formulation may primarily affect the skin surface or nearby tissues.
A transdermal product is specifically designed to deliver compounds through the skin into systemic circulation.
Bisabolol content alone does not make a product transdermal.
Can Bisabolol Treat Eczema?
Current evidence does not justify treating cannabis-derived bisabolol as an eczema medication.
Human dermatology studies involving bisabolol-containing formulations are encouraging, but many used combination products rather than purified bisabolol.
Patients with persistent eczema, dermatitis, infection, severe itching, open wounds, or rapidly changing skin symptoms should seek appropriate medical evaluation.
Cannabis terpene information should not replace dermatologic diagnosis or treatment.
How to Read Bisabolol on a Cannabis Lab Report
A terpene panel might show:
Total terpenes: 2.00%
Beta-caryophyllene: 0.70%
Limonene: 0.40%
Linalool: 0.20%
Humulene: 0.18%
Bisabolol: 0.07%
In this example, bisabolol is measurable but represents a relatively small portion of the complete profile.
That is common.
A small percentage can still be useful for chemical identification, but it should not be interpreted as a clinical dose.
Green Dragon Florida Products With Bisabolol
These products illustrate how bisabolol appears within complete cannabis terpene profiles.
They are not recommendations for treating eczema, skin inflammation, wounds, or other dermatologic conditions.
Green Dragon Cherry Punch Kush Flower — Ocala
Green Dragon Cherry Punch Kush Flower is currently listed at approximately 20.7% THC and 1.90% total terpenes.
Its current laboratory profile contains approximately 0.073% bisabolol, alongside beta-caryophyllene, limonene, linalool, humulene, and pinene.
This provides a good example of bisabolol appearing as a secondary component within a broader terpene profile.
Green Dragon Coco-Nutty #2 Flower — Palatka
Green Dragon Coco-Nutty #2 Flower is currently listed at approximately 23.5% THC and 1.82% total terpenes.
The current batch lists approximately 0.057% bisabolol.
Beta-caryophyllene is much more abundant, demonstrating why patients should examine the complete terpene profile rather than assuming one minor compound defines the product.
Green Dragon Punch Cake #2 Flower — Ocala
Green Dragon Punch Cake #2 Flower is currently available with approximately 20.9% THC and 2.58% total terpenes on the current Ocala menu.
Because individual terpene values can change between batches, patients interested specifically in bisabolol should review the current Full Lab Data before purchasing.
Product availability, cannabinoid potency, and terpene percentages may change by Green Dragon Florida location and batch.
The Green Dragon Takeaway
Bisabolol is one of the more interesting cannabis terpenes from a dermatologic perspective.
Laboratory and animal research supports anti-inflammatory and skin-related biological activity, while some human clinical studies involving bisabolol-containing formulations have reported improvements in itching, dermatitis symptoms, and wound outcomes.
But much of the human evidence comes from multi-ingredient formulations.
That means bisabolol should not be treated as a proven standalone treatment for eczema, wounds, inflammation, or another skin disorder.
For medical cannabis patients, bisabolol is best viewed as one component of the product's chemical fingerprint.
Its dermatologic research is promising—but the concentration found naturally in cannabis and the clinical effects of purified topical formulations are not the same thing.